A new patient self-assessment tool shows promise as a simple measure of the overall impact of rheumatoid arthritis on a patient, but will it be able to gain the international acceptance required to become a clinical standard?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The Portuguese Rheumatoid Arthritis Impact of Disease (RAID) score and its measurement equivalence in three countries: validation study using Rasch Models
Quality of Life Research Open Access 01 August 2018
-
Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials
Critical Care Open Access 13 May 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gossec, L. et al. Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative. Ann. Rheum. Dis. 70, 935–942 (2011).
Boers, M. RAID: a valid tool to quantify the impact of rheumatoid arthritis. But what impact will it have on the core set for trials? Ann. Rheum. Dis. 70, 884–885 (2011).
Boers, M., Brooks, P., Strand, C. V. & Tugwell, P. The OMERACT filter for Outcome Measures in Rheumatology. J. Rheumatol. 25, 198–199 (1998).
Bruce, B. & Fries, J. F. The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual. Life Outcomes 1, 20 (2003).
Huskisson, E. C. Measurement of pain. Lancet 2, 1127–1131 (1974).
Houssien, D. A., Stucki, G. & Scott, D. L. A patient-derived disease activity score can substitute for a physician-derived disease activity score in clinical research. Rheumatology (Oxford) 38, 48–52 (1999).
de Jong, Z., van der Heijde, D., McKenna, S. P. & Whalley, D. The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument. Br. J. Rheumatol. 36, 878–883 (1997).
[No authors listed] EuroQol— a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 16, 199–208 (1990).
Tosh, J. C., Wailoo, A. J., Scott, D. L. & Deighton, C. M. Cost-effectiveness of combination nonbiologic disease-modifying antirheumatic drug strategies in patients with early rheumatoid arthritis. J. Rheumatol. doi:10.3899/jrheum.101327.
Scott, D. L., Khoshaba, B., Choy, E. H. & Kingsley, G. H. Limited correlation between the Health Assessment Questionnaire (HAQ) and EuroQol in rheumatoid arthritis: questionable validity of deriving quality adjusted life years from HAQ. Ann. Rheum. Dis. 66, 1534–1537 (2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Gullick, N., Scott, D. Clinical utility of the RAID (RA impact of disease) score. Nat Rev Rheumatol 7, 499–500 (2011). https://doi.org/10.1038/nrrheum.2011.105
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2011.105
This article is cited by
-
The Portuguese Rheumatoid Arthritis Impact of Disease (RAID) score and its measurement equivalence in three countries: validation study using Rasch Models
Quality of Life Research (2018)
-
A simple and novel technique for regional citrate anticoagulation during intermittent hemodialysis may obviate the need for calcium monitoring
Intensive Care Medicine (2017)
-
Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials
Critical Care (2016)
